$1.19+0.04 (+3.48%)
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.
MaxCyte, Inc. in the Healthcare sector is trading at $1.19 with a market capitalization of $127M. Wall Street consensus targets $4.11 (4 analysts), implying a +245.2% move over the next 12 months. The stock is currently 50% below its 52-week high of $2.38, remaining 2.5% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale t...
Gainers Quantum Cyber (NASDAQ:QUCY) shares rose 163.0% to $0.85 during Wednesday's regular session. The market value of their outstanding shares is at $4.0 million. Whitehawk Therapeutics (NASDAQ:WHWK) stock moved upwards by 29.59% to $5.08. The company's market cap stands at $193.8 million. As per the news, the Q1 earnings report came out 4 days ago. Replimune Group (NASDAQ:REPL) stock moved upwards by 29.09% to $5.28. The market value of their outstanding shares is at $320.8 million. MaxCyte (
Minot Light Capital Partners, an investment management company, released its “Capital Appreciation Fund” Q1 2026 Investor Letter. A copy of the letter can be downloaded here. The fund declined by 2.7% in the first quarter of 2026 due to a sharp macro-driven sector rotation following geopolitical tensions, which triggered inflation fears and rising interest rate […]
View more earnings on CSCO With U.S. stock futures trading mixed this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Cisco Systems Inc. (NASDAQ:CSCO) to report quarterly earnings at $1.03 per share on revenue of $15.56 billion after the closing bell, according to data from Benzinga Pro. Cisco shares gained 0.2% to $99.53 in after-hours trading. MaxCyte Inc. (NASDAQ:MXCT) reported better-than-expected first-quarter financial results
MaxCyte Inc (MXCT) reports steady revenue and a robust balance sheet, but faces challenges in core revenue and gross margin.
MaxCyte (NASDAQ:MXCT) reported lower first-quarter revenue compared with the prior year, as management said discontinued SPL programs and inventory management by its largest customer weighed on core revenue, while milestone revenue from a registrational-stage program helped offset part of the declin